Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kingham

Showing results (241-250 of 465) with videos related to

Pageof 47
Sort By:
Annals of Surgery|June 28, 2024
Safety of Selective Operative Drainage After Pancreatic Resection: A Retrospective Analysis of 2,607 PatientsJosephine Magnin, Joshua S Jolissaint, Hannah E Fuchs, et al.
JCO Global Oncology|October 17, 2024
Delays in Presentation, Diagnosis, and Treatment Among Patients With GI Cancer in Southwest NigeriaJustina Ucheojor Onwuka, Funmilola Olanike Wuraola, Israel Adeyemi Owoade, et al.
Annals of Surgery|March 21, 2014
Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomesMichael I DʼAngelica, Camilo Correa-Gallego, Philip B Paty, et al.
Annals of Surgery|November 20, 2020
Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery ChemotherapyJashodeep Datta, Raja R Narayan, Debra A Goldman, et al.
Cancer|December 24, 2015
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy aloneIoannis T Konstantinidis, Bas Groot Koerkamp, Richard K G Do, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 28, 2021
Percutaneous liver venous deprivation: outcomes in heavily pretreated metastatic colorectal cancer patientsMario Ghosn, T Peter Kingham, Fourat Ridouani, et al.
Annals of Surgical Oncology|April 30, 2025
Combined Portal and Hepatic Vein Embolization Produces Greater Hypertrophy than Portal Vein Embolization Alone with Similar Post-Hepatectomy Outcomes and is not Impacted by Hepatic Artery Infusion ChemotherapyAnkur P Choubey, Joanne F Chou, Kevin C Soares, et al.
Journal of Surgical Oncology|September 25, 2020
Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastasesRami M Srouji, Raja R Narayan, Thomas Boerner, et al.
World Journal of Surgery|August 15, 2019
Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic ChemotherapyFlorian E Buisman, Boris Galjart, Eric P van der Stok, et al.
Journal of the American College of Surgeons|January 26, 2015
Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancerAmber L Simpson, Julie N Leal, Amudhan Pugalenthi, et al.
Pageof 47

Showing results (241-250 of 465) with videos related to

Sort By:
Pageof 47
Annals of Surgery|June 28, 2024
Safety of Selective Operative Drainage After Pancreatic Resection: A Retrospective Analysis of 2,607 PatientsJosephine Magnin, Joshua S Jolissaint, Hannah E Fuchs, et al.
JCO Global Oncology|October 17, 2024
Delays in Presentation, Diagnosis, and Treatment Among Patients With GI Cancer in Southwest NigeriaJustina Ucheojor Onwuka, Funmilola Olanike Wuraola, Israel Adeyemi Owoade, et al.
Annals of Surgery|March 21, 2014
Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomesMichael I DʼAngelica, Camilo Correa-Gallego, Philip B Paty, et al.
Annals of Surgery|November 20, 2020
Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery ChemotherapyJashodeep Datta, Raja R Narayan, Debra A Goldman, et al.
Cancer|December 24, 2015
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy aloneIoannis T Konstantinidis, Bas Groot Koerkamp, Richard K G Do, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 28, 2021
Percutaneous liver venous deprivation: outcomes in heavily pretreated metastatic colorectal cancer patientsMario Ghosn, T Peter Kingham, Fourat Ridouani, et al.
Annals of Surgical Oncology|April 30, 2025
Combined Portal and Hepatic Vein Embolization Produces Greater Hypertrophy than Portal Vein Embolization Alone with Similar Post-Hepatectomy Outcomes and is not Impacted by Hepatic Artery Infusion ChemotherapyAnkur P Choubey, Joanne F Chou, Kevin C Soares, et al.
Journal of Surgical Oncology|September 25, 2020
Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastasesRami M Srouji, Raja R Narayan, Thomas Boerner, et al.
World Journal of Surgery|August 15, 2019
Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic ChemotherapyFlorian E Buisman, Boris Galjart, Eric P van der Stok, et al.
Journal of the American College of Surgeons|January 26, 2015
Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancerAmber L Simpson, Julie N Leal, Amudhan Pugalenthi, et al.
Pageof 47